S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

XENE Xenon Pharmaceuticals Inc

42.49

0.00 (0.00%)

Pre Market

Last Updated: 18:09:48

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Xenon Pharmaceuticals Charts.

Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Xenon Pharmaceuticals Charts.

Xenon Pharmaceuticals Inc. News

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
Friday 5 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

More Xenon Pharmaceuticals Inc. News Articles

Australia And New Zealan...

Commonwealth Bank Of Aus...

S&P ASX 300 Metals and M...

Invesco QQQ Trust Series 1

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions